glp 1 financial assistance Express Scripts expands Patient Assurance Program to drive affordability and access to GLP-1s Understanding GIP & GLP-1 Medications

Orderly Meds Reviews is a comparison platform for compounded GLP-1 providers

Diabetes GLP-1s perform better but still leak demand: Diabetes-indicated GLP-1s show higher retention (24% at one year) and face fewer access hurdles due to broader coverage and disease framing, yet 76% of demand remains unmet

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability

Projected global sales by 2030 for GLP-1 could increase by 2.6x

Maritide, a once-monthly weight loss drug, faces high discontinuation rates in Phase II trials